GABA produced by multiple bone marrow cell types regulates hematopoietic stem and progenitor cells

Area of Science:

• Hematology
• Neuroscience
• Metabolism

Background:

• Hematopoietic stem and progenitor cells (HSPCs) are crucial for blood system homeostasis.
• The bone marrow microenvironment contains unknown signals regulating HSPC proliferation and differentiation.

Purpose of the Study:

• To investigate the role of gamma-aminobutyric acid (GABA) as a regulator of HSPCs in the bone marrow.
• To identify the sources of GABA that influence HSPC activity.

Main Methods:

• Genetic deletion of glutamate decarboxylase enzymes (Gad1 and Gad2) in B lineages and endothelial cells (ECs).
• Assessing the impact of GABA production blockade on HSPC numbers and GABA levels in the bone marrow.
• Analyzing gene expression profiles of HSPCs under altered GABA conditions.

Main Results:

• Simultaneous blockade of GABA production from hematopoietic cells and ECs significantly reduced HSPC numbers and bone marrow GABA levels.
• Lowered GABA levels in the bone marrow altered HSPC gene expression, decreasing proliferation markers and increasing B lineage markers.
• Deletion of GABA-producing genes in either B lineages or ECs alone had a minor effect on HSPCs.

Conclusions:

• GABA, produced by multiple cell types including hematopoietic cells and ECs, acts as a key regulator of HSPC activity.
• Bone marrow GABA levels are critical for balancing HSPC proliferation and differentiation, thus maintaining blood homeostasis.